BridgeBio Oncology Therapeutics, Inc. (BBOT)
BridgeBio Oncology Therapeutics, Inc. (BBOT) Insider Trading
Directors, officers and holders of more than 10% of BBOT report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 62 transactions on file: 0 with code P, 0 with code S and 50 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Cobo Marc | Principal Accounting Officer | F Tax Payment | 203 | $2.68 | $544 |
| Oct 1, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | F Tax Payment | 343 | $3.94 | $1,351 |
| Oct 1, 2026 | Cobo Marc | Principal Accounting Officer | F Tax Payment | 126 | $3.94 | $496 |
| Oct 1, 2026 | Ben Yong | Chief Med & Dev Officer | F Tax Payment | 1,047 | $3.94 | $4,125 |
| Oct 1, 2026 | Beltran Pedro | President and CEO | F Tax Payment | 1,047 | $3.94 | $4,125 |
| Sep 10, 2026 | Cobo Marc | Principal Accounting Officer | A Award | 9,038 | Not measured | Not measured |
| Sep 10, 2026 | Cobo Marc | Principal Accounting Officer | F Tax Payment | 203 | $5.52 | $1,121 |
| Sep 10, 2026 | Cobo Marc | Principal Accounting Officer | A Award | 43,700 | Not measured | Not measured |
| Jul 1, 2026 | Chen Bihua | Director | J Other | 4,528,186 | Not measured | Not measured |
| Jul 1, 2026 | Beltran Pedro | President and CEO | F Tax Payment | 1,047 | $7.80 | $8,167 |
| Jul 1, 2026 | Chen Bihua | Director | J Other | 130,865 | Not measured | Not measured |
| Jul 1, 2026 | Ben Yong | Chief Med & Dev Officer | F Tax Payment | 1,047 | $7.80 | $8,167 |
| Jul 1, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | F Tax Payment | 343 | $7.80 | $2,675 |
| Jul 1, 2026 | Cobo Marc | Principal Accounting Officer | F Tax Payment | 125 | $7.80 | $975 |
| Jul 1, 2026 | Chen Bihua | Director | J Other | 1,704,862 | Not measured | Not measured |
| Jul 1, 2026 | Chen Bihua | Director | J Other | 2,692,459 | Not measured | Not measured |
| Jun 16, 2026 | Kelleher Raymond J. | Director | A Award | 31,675 | Not measured | Not measured |
| Jun 16, 2026 | MCCORMICK FRANK | Director | A Award | 31,675 | Not measured | Not measured |
| Jun 16, 2026 | Tipirneni Praveen P. | Director | A Award | 31,675 | Not measured | Not measured |
| Jun 16, 2026 | Chen Bihua | Director | A Award | 31,675 | Not measured | Not measured |
| Jun 16, 2026 | Bauer Jake | Director | A Award | 31,675 | Not measured | Not measured |
| Jun 16, 2026 | Kumar Neil | Director | A Award | 31,675 | Not measured | Not measured |
| Jun 16, 2026 | Lebowitz Peter F | Director | A Award | 7,289 | Not measured | Not measured |
| May 10, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | A Award | 758,222 | Not measured | Not measured |
| May 10, 2026 | Beltran Pedro | President and CEO | A Award | 1,103,837 | Not measured | Not measured |
| Apr 1, 2026 | Ben Yong | Chief Med & Dev Officer | F Tax Payment | 1,047 | $9.03 | $9,454 |
| Apr 1, 2026 | Mehra Uneek | Chief Financial Officer | F Tax Payment | 524 | $9.03 | $4,732 |
| Apr 1, 2026 | Beltran Pedro | President and CEO | F Tax Payment | 1,047 | $9.03 | $9,454 |
| Mar 24, 2026 | Lebowitz Peter F | Director | A Award | 63,350 | Not measured | Not measured |
| Mar 10, 2026 | Beltran Pedro | President and CEO | A Award | 210,000 | Not measured | Not measured |
| Mar 10, 2026 | Mehra Uneek | Chief Financial Officer | A Award | 23,330 | Not measured | Not measured |
| Mar 10, 2026 | Beltran Pedro | President and CEO | A Award | 46,670 | Not measured | Not measured |
| Mar 10, 2026 | Ben Yong | Chief Med & Dev Officer | A Award | 46,670 | Not measured | Not measured |
| Mar 10, 2026 | Ben Yong | Chief Med & Dev Officer | A Award | 210,000 | Not measured | Not measured |
| Mar 10, 2026 | Mehra Uneek | Chief Financial Officer | A Award | 105,000 | Not measured | Not measured |
| Jan 1, 2026 | Wallace Eli M. | Chief Executive Officer | A Award | 1,114,400 | Not measured | Not measured |
| Dec 10, 2025 | Wallace Eli M. | Chief Executive Officer | D Disposition | 1,114,400 | Not measured | Not measured |
| Oct 10, 2025 | BridgeBio Pharma LLC | 10% Owner | J Other | 784,720 | Not measured | Not measured |
| Oct 2, 2025 | Wallace Eli M. | Chief Executive Officer | A Award | 1,614,400 | Not measured | Not measured |
| Aug 26, 2025 | Wallace Eli M. | Chief Executive Officer | A Award | 499,731 | Not measured | Not measured |
| Aug 26, 2025 | Beltran Pedro | President and CEO | A Award | 357,177 | Not measured | Not measured |
| Aug 26, 2025 | Bauer Jake | Director | A Award | 138,193 | Not measured | Not measured |
| Aug 26, 2025 | Tipirneni Praveen P. | Director | A Award | 52,269 | Not measured | Not measured |
| Aug 26, 2025 | MCCORMICK FRANK | Director | A Award | 91,076 | Not measured | Not measured |
| Aug 26, 2025 | Mehra Uneek | Chief Financial Officer | A Award | 633,570 | Not measured | Not measured |
| Aug 26, 2025 | Ben Yong | Chief Med & Dev Officer | A Award | 357,177 | Not measured | Not measured |
| Aug 11, 2025 | Chen Bihua | Director | A Award | 1,762,760 | Not measured | Not measured |
| Aug 11, 2025 | Chen Bihua | Director | A Award | 1,905,046 | Not measured | Not measured |
| Aug 11, 2025 | Chen Bihua | Director | A Award | 5,598,425 | $10.72 | $60,000,000 |
| Aug 11, 2025 | Chen Bihua | Director | A Award | 639,110 | $10.72 | $6,849,534 |
The full Form 4 history is on the BBOT company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.